Molecular markers help predict oral cancer progression
A group of molecular markers has been identified that can help clinicians determine which patients with low-grade oral premalignant lesions are at high risk for progression to oral cancer, according to data from the Oral Cancer Prediction Longitudinal Study published in Cancer Prevention Research (August 21, 2012). “The results of our study should help to build awareness that not everyone with a low-grade oral premalignant lesion will progress to cancer,”

